Seneca Biopharma (STU:7NS2) FCF Margin % : -90,200.00% (As of Dec. 2020)

View and export this data going back to 2013. Start your Free Trial

What is Seneca Biopharma FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Seneca Biopharma's Free Cash Flow for the three months ended in Dec. 2020 was €-1.80 Mil. Seneca Biopharma's Revenue for the three months ended in Dec. 2020 was €0.00 Mil. Therefore, Seneca Biopharma's FCF Margin % for the quarter that ended in Dec. 2020 was -90,200.00%.

As of today, Seneca Biopharma's current FCF Yield % is 0.00%.

The historical rank and industry rank for Seneca Biopharma's FCF Margin % or its related term are showing as below:

STU:7NS2' s FCF Margin % Range Over the Past 10 Years
Min: -59830.77 Med: 0 Max: 0
Current: -59830.77

STU:7NS2's FCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -147.18 vs STU:7NS2: -59830.77

Seneca Biopharma FCF Margin % Historical Data

The historical data trend for Seneca Biopharma's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Seneca Biopharma FCF Margin % Chart

Seneca Biopharma Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

FCF Margin %

Get a 7-Day Free Trial

-99,713.33

-5,189.09

-2,953.28

-46,642.86

-61,825.00

Seneca Biopharma Quarterly Data
	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20
FCF Margin %	Get a 7-Day Free Trial															-61,466.67	-30,380.00	-61,200.00	-87,300.00	-90,200.00

Competitive Comparison of Seneca Biopharma's FCF Margin %

For the Biotechnology subindustry, Seneca Biopharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Seneca Biopharma's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Seneca Biopharma's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Seneca Biopharma's FCF Margin % falls into.

Seneca Biopharma FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Seneca Biopharma's FCF Margin for the fiscal year that ended in Dec. 2020 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2020 )	/	Revenue (A: Dec. 2020 )
	=	-7.419	/	0.012
	=	-61,825.00 %

Seneca Biopharma's FCF Margin for the quarter that ended in Dec. 2020 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2020 )	/	Revenue (Q: Dec. 2020 )
	=	-1.804	/	0.002
	=	-90,200.00 %

Seneca Biopharma FCF Margin % Related Terms

Thank you for viewing the detailed overview of Seneca Biopharma's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Seneca Biopharma (STU:7NS2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Seneca Biopharma Inc (STU:7NS2) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

20271 Goldenrod Lane, Suite 2024, Germantown, MD, USA, 20876

Website

https://www.senecabio.com

Seneca Biopharma Inc is a clinical-stage biopharmaceutical company developing novel treatments for diseases of high unmet medical need. It is focused on the research and development of nervous system therapies based on proprietary human neural stem cells and small molecule compounds.

Seneca Biopharma (STU:7NS2) Headlines

No Headlines